• 1. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 2. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 3. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 5. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Recent Advances in the Study of 2-Amino-4,4-dimethylpentanoic acid (CAS: 106247-35-2)

2-Amino-4,4-dimethylpentanoic acid (CAS: 106247-35-2) is a non-proteinogenic amino acid that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its unique structural properties and potential therapeutic applications. Recent studies have explored its role as a building block in peptide synthesis, its metabolic pathways, and its interactions with biological targets. This research brief synthesizes the latest findings on this compound, providing insights into its chemical behavior, biological activity, and potential applications in drug development.

One of the key areas of research has been the incorporation of 2-Amino-4,4-dimethylpentanoic acid into peptide chains to modulate their stability and bioactivity. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that peptides containing this amino acid exhibit enhanced resistance to enzymatic degradation, making them promising candidates for the development of long-acting therapeutics. The study utilized solid-phase peptide synthesis (SPPS) to incorporate the compound into model peptides, followed by rigorous pharmacokinetic and pharmacodynamic analyses.

Another significant advancement involves the investigation of 2-Amino-4,4-dimethylpentanoic acid as a modulator of metabolic pathways. Research published in Bioorganic & Medicinal Chemistry Letters in early 2024 highlighted its role in inhibiting key enzymes involved in amino acid metabolism, suggesting potential applications in metabolic disorder treatments. The study employed a combination of in vitro enzyme assays and molecular docking simulations to elucidate the compound's mechanism of action.

In addition to its biochemical applications, recent work has explored the synthetic routes to 2-Amino-4,4-dimethylpentanoic acid, aiming to improve yield and scalability. A 2023 paper in Organic Process Research & Development described a novel catalytic asymmetric synthesis method that significantly enhances the enantiomeric purity of the compound, which is critical for its use in chiral drug development. The method utilizes a palladium-catalyzed asymmetric hydrogenation, achieving >99% enantiomeric excess (ee).

Looking ahead, researchers are particularly interested in the potential of 2-Amino-4,4-dimethylpentanoic acid to serve as a scaffold for the development of novel antimicrobial agents. Preliminary data from a 2024 study presented at the American Chemical Society National Meeting indicated that derivatives of this amino acid exhibit potent activity against multidrug-resistant bacterial strains. These findings open new avenues for addressing the global challenge of antibiotic resistance.

In conclusion, the growing body of research on 2-Amino-4,4-dimethylpentanoic acid (CAS: 106247-35-2) underscores its versatility and potential in various biomedical applications. From peptide therapeutics to metabolic modulators and antimicrobial agents, this compound continues to reveal new possibilities for drug discovery and development. Future studies are expected to further explore its pharmacological properties and optimize its synthetic accessibility for broader application in the pharmaceutical industry.

• 308807-04-7((2S)-2-amino-4,4-dimethylhexanoic acid)
• 142886-11-1(2-amino-6,6-dimethylheptanoic acid)
• 142927-20-6((2R)-2-amino-6,6-dimethylheptanoic acid)
• 627910-24-1(2-amino-4,6,6-trimethylheptanoic acid)
• 60122-72-7(BETA-TBU-DL-ALANINE)
• 142886-12-2((2R)-2-amino-5,5-dimethylhexanoic acid)
• 88319-43-1((2R)-2-amino-4,4-dimethylpentanoic acid)
• 57224-50-7(4-Methyl-L-leucine)
• 59759-95-4(Pentanoic acid,2-amino-3,4,4-trimethyl-)
• 142886-13-3((2S)-2-amino-5,5-dimethylhexanoic acid)